-

Outlook on the Worldwide Dietary Supplement Industry to 2028 - Growing Attention Towards Plant-Based Supplements Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Dietary Supplement Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.

According to a new report on the global dietary supplement market, the industry is likely to augment at a CAGR of 8.91% in the forthcoming period 2019-2028.

Since there is an increase in health awareness among the people, considerable growth in the demand for supplements is witnessed in the health & wellness industry. The growing sports and medical nutrition segments, coupled with the prevalence of active living, is also aiding the global market growth. Key opportunities like the demand for nutraceutical products in the e-commerce domain and the increasing attention towards plant-based supplements must be leveraged so as to gain the projected growth. However, easily available counterfeit products and regulatory concerns are restraining the market growth. In addition, the rising demand for functional foods and damaging publicity of the products regarding its efficacy are affecting the market growth.

The global market report covers the countries from North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa.

According to the geographical landscape, Asia-Pacific is expected to be the fastest-growing region for the dietary supplement market in the forecasted years. The growing geriatric population and their need for these products, coupled with the increasing health-consciousness and lifestyle changes among the general public in countries like China, Japan, Australia and India, are the main factors driving the growth of the dietary supplement market in Asia-Pacific. Moreover, the government in China has been taking several initiatives to promote the adoption of dietary supplements in the country, thereby helping the regional market growth.

Companies Mentioned

  • Abbott
  • Bayer AG
  • Glanbia plc
  • GlaxoSmithKline plc
  • Herbalife International Inc
  • Merck Kgaa
  • Otsuka Holdings Co Ltd
  • Pfizer Inc
  • Reckitt Benckiser Group plc
  • Sanofi
  • Suntory Holdings Limited
  • Nature's Bounty
  • Amway
  • General Nutrition Centers Inc
  • Blackmores Group

Key Topics Covered:


1. Global Dietary Supplement Market - Summary


2. Industry Outlook

2.1. Market Definition

2.2. Key Insights

2.2.1. Asia-Pacific Leads the Overall Market

2.2.2. Surging Demand for Multivitamin Tablets

2.2.3. Increase in Aging Population Worldwide

2.3. Porter's Five Force Analysis

2.4. Key Impact Analysis

2.5. Impact of Covid on Dietary Supplements

2.6. Market Attractiveness Index

2.7. Vendor Scorecard

2.8. Market Drivers

2.8.1. Raised Demand for Supplements in Health and Wellness Industry

2.8.2. Promising Outlook Towards Sports Nutrition

2.8.3. Burgeoning Interest in Medical Nutrition

2.8.4. Rise in Prevalence of Active Living

2.9. Market Restraints

2.9.1. Accessibility of Counterfeit Products

2.9.2. Regulatory Concerns Affects the Market Growth

2.10. Market Opportunities

2.10.1. Budding Demand for Nutraceutical Products in E-Commerce Domain

2.10.2. Growing Attention Towards Plant-Based Supplements

2.11. Market Challenges

2.11.1. Escalating Demand for Functional Foods

2.11.2. Damaging Publicity Affecting the Overall Market


3. Global Dietary Supplement Market Outlook - by Ingredients

3.1. Botanicals

3.2. Vitamins

3.3. Minerals

3.4. Amino Acids

3.5. Enzymes

3.6. Others


4. Global Dietary Supplement Market Outlook - by Product

4.1. Tablets

4.2. Capsules

4.3. Powder

4.4. Liquids

4.5. Soft Gels

4.6. Gel Caps


5. Global Dietary Supplement Market Outlook - by Application

5.1. Additional Supplements

5.2. Medicinal Supplements

5.3. Sports Nutrition


6. Global Dietary Supplement Market Outlook - by End-User

6.1. Infant

6.2. Children

6.3. Adults

6.4. Pregnant Women

6.5. Old-Aged


7. Global Dietary Supplement Market - Regional Outlook

7.1. North America

7.2. Europe

7.3. Asia-Pacific

7.4. Latin America

7.5. Middle East and Africa


8. Competitive Landscape


9. Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/p0qt6v.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Computer System Validation (CSV) Training Course: Regulations Impacting Your Systems and Hands-on Practice Writing Validation Documents (Jan 27th - Jan 29th, 2026 & On-Demand) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Computer System Validation (CSV) Training Course (Jan 27th - Jan 29th, 2026)" training has been added to ResearchAndMarkets.com's offering. A course designed to completely immerse you in computer system validation. This course delivers comprehension of the regulations impacting your systems and hands-on practice writing validation documents. You will leave ready to lead efficient, effective, inspection- ready validation projects. Registration Includes: Checklist of...

Understanding Medical Device Regulatory Pathways - 510(k), PMA & Exemptions Webinar - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Understanding Medical Device Regulatory Pathways - 510(k), PMA & Exemptions (January 15, 2026)" training has been added to ResearchAndMarkets.com's offering. This expert-led 3-hour webinar provides a comprehensive introduction to the key regulatory pathways for medical device submissions in the US market. The regulation and control of new or substantially changed medical devices for sale in the US is based on the 510(k), PMA or DeNovo submission process. This w...

Medical Devices: Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) Course: Developing Effective Post Market Surveillance and Complaint Handling Systems Training - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Medical Devices: Developing Effective Post Market Surveillance and Complaint Handling Systems Course (Jan 22nd - Jan 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering. What are U.S. FDA CGMP expectations/requirements for Post Market Surveillance and Complaint Handling? This seminar will examine Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), as well as appropriate articles / Annexes of the EU's MDR, which require manu...
Back to Newsroom